IDERA PHARMACEUTICALS INC - COM PAR (IDRA)

CUSIP: 45168K405

Q4 2018 13F Holders as of 31 Dec 2018

Type / Class
Equity / COM PAR
Total 13F shares
12,288,514
Share change
+1,297,439
Total reported value
$34,038,593
Price per share
$2.77
Number of holders
81
Value change
+$2,565,312
Number of buys
47
Number of sells
19

Quarterly Holders Quick Answers

What is CUSIP 45168K405?
CUSIP 45168K405 identifies IDRA - IDERA PHARMACEUTICALS INC - COM PAR in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of IDERA PHARMACEUTICALS INC - COM PAR (IDRA) as of Q4 2018

As of 31 Dec 2018, IDERA PHARMACEUTICALS INC - COM PAR (IDRA) was held by 81 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 12,288,514 shares. The largest 10 holders included BAKER BROS. ADVISORS LP, BlackRock Inc., MILLENNIUM MANAGEMENT LLC, Broadfin Capital, LLC, Vanguard Group Inc, SPHERA FUNDS MANAGEMENT LTD., NATIXIS, STATE STREET CORP, Assenagon Asset Management S.A., and Candriam Luxembourg S.C.A.. This page lists 81 institutional shareholders reporting positions in this security for the Q4 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.